Bone, sweet bone--osteoporotic fractures in diabetes mellitus. - Wikidata - wikimedia - TriplyDB

Bone, sweet bone--osteoporotic fractures in diabetes mellitus.

Bone, sweet bone--osteoporotic fractures in diabetes mellitus.

http://www.wikidata.org/entity/Q37976305

about

Metformin Improves Diabetic Bone Health by Re-Balancing Catabolism and Nitrogen Disposal Autophagy impairment aggravates the inhibitory effects of high glucose on osteoblast viability and function Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis.Epidemiology of Fractures in Diabetes.Retinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling.Dipeptidyl peptidase-4 inhibitors and prevention of bone fractures: Effects beyond glyemic control.Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas.Insulin use and Excess Fracture Risk in Patients with Type 2 Diabetes: A Propensity-Matched cohort analysis.The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes.Osteoporosis, fractures, and diabetes.Does bone resorption stimulate periosteal expansion? A cross-sectional analysis of β-C-telopeptides of type I collagen (CTX), genetic markers of the RANKL pathway, and periosteal circumference as measured by pQCT.Leptin receptor deficient diabetic (db/db) mice are compromised in postnatal bone regeneration.Chronic ingestion of advanced glycation end products induces degenerative spinal changes and hypertrophy in aging pre-diabetic mice.Association between metabolic syndrome and bone fractures: a meta-analysis of observational studies Association of calcaneal quantitative ultrasound parameters with metabolic syndrome in middle-aged and elderly Chinese: a large population-based cross-sectional study Layer-by-layer paper-stacking nanofibrous membranes to deliver adipose-derived stem cells for bone regeneration Physiology of Mechanotransduction: How Do Muscle and Bone "Talk" to One Another?The use of alendronate is associated with a decreased incidence of type 2 diabetes mellitus--a population-based cohort study in Taiwan.High insulin levels in KK-Ay diabetic mice cause increased cortical bone mass and impaired trabecular micro-structure.The effects of acute hyperinsulinemia on bone metabolism.Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using The Health Improvement Network (THIN).Influence of high glucose and advanced glycation end-products (ages) levels in human osteoblast-like cells gene expression.Decreased Bone Mineral Density at the Femoral Neck and Lumbar Spine in South Indian Patients with Type 2 Diabetes.Determinants of bone strength and quality in diabetes mellitus in humans.Effects of TZD Use and Discontinuation on Fracture Rates in ACCORD Bone Study Organ-based response to exercise in type 1 diabetes.Efficacy and Safety of Risedronate in Osteoporosis Subjects with Comorbid Diabetes, Hypertension, and/or Dyslipidemia: A Post Hoc Analysis of Phase III Trials Conducted in Japan.Biphasic Response to Luteolin in MG-63 Osteoblast-Like Cells under High Glucose-Induced Oxidative Stress.Beyond glycemic control in diabetes mellitus: effects of incretin-based therapies on bone metabolism.Validity of leptin receptor-deficiency (db/db) type 2 diabetes mellitus mice as a model of secondary osteoporosis Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures Diabetes-related impairment in bone strength is established early in the life course.Effect of Intravenous Glucose Tolerance Test on Bone Turnover Markers in Adults with Normal Glucose Tolerance.The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing.Total hip arthroplasty complications in patients with or without controlled diabetes mellitus during hospitalization.Diabetes and bone health: latest evidence and clinical implications.Type 1 diabetes and osteoporosis: A review of literature Heart failure as a risk factor for osteoporosis and fractures.Role of vitamin D in the development of insulin resistance and type 2 diabetes.Impact of diabetes and its treatments on skeletal diseases.

P2860

Q28551882-83A08EEF-4E44-472C-AC58-93FAEF3F466B Q28585332-6830AABF-39F4-43D5-8897-0BFD89D41B06 Q30234664-1B12F328-A063-43B8-871A-E76BE05EDA5C Q30248863-210A8ACC-AD70-4AA9-A572-8B03D10751DC Q30619787-8110CBDE-8D5D-4810-AA54-0C3A129308C1 Q33603342-5C56C04C-6134-4476-8325-ED2A7E785B4F Q33603384-C511C40B-958E-484B-949C-4032B73F7BF4 Q33812674-FC26DC34-F105-40B0-B339-E28CB058AC37 Q33867998-5DD8284F-EE57-444D-903A-0AB54E0E4702 Q33891378-0CED8961-0137-4A81-AB31-CB1E3A382BBF Q34069530-57F51A40-3BCF-42BB-8607-E8777C3FEE59 Q34392265-E7763E17-CC28-4C5F-910D-50EA26A4DD94 Q35068710-F7FDAA67-DC00-4EA2-A9E1-BB44A3612E44 Q35088955-C7BE1FE9-DBBD-44CA-A5CE-F83612FA426C Q35094649-716CFF5F-8D9B-433E-9AF3-BFB42F6F7F14 Q35101019-98FD71F9-C6E0-4CD1-A514-EB7D34319CE2 Q35234328-CA4A8630-0F8F-495B-BF8B-5DEEB13F7174 Q35391518-560B4821-795C-48EC-8AFC-21C789D77829 Q35585640-3976A053-ECEF-41FA-9BE2-E24B6437FD7F Q35833587-9231EAB8-EB4E-4AB4-A9A5-6D41A3183441 Q36087289-F83A2DEF-FF05-4DC9-96ED-D362F9717E35 Q36119266-B56D9D30-00F6-42B1-92F7-051BD44F8FF0 Q36163043-AF13313F-385F-4B87-AFB5-A6031DB3B5F9 Q36373016-C74148AC-5B68-4E1B-818A-8E9D801B672A Q36433551-82B6791B-636E-4EB6-B0D0-1B0FD99B5ADF Q36455541-75EAE72A-C083-4B19-BBA2-804BBC854B6C Q36492288-F463E220-F7C0-41A0-B905-63820D6F4A6D Q36611321-E04CD804-9792-4117-AA16-F37474D98EDF Q36935346-936812EB-F592-4580-86E4-21B43BC8F726 Q36990610-F9702D3F-B45A-4B44-B535-E31E5B90BF4A Q37101614-877F0979-86D7-4A3E-839B-EA2F9C9F4DBF Q37101627-ECB3FDDA-8FC3-48C3-8F0D-63B48B03A68D Q37142475-E662EB71-55F9-4C41-9676-A7F2FBF669BE Q37182800-BE6A12CF-1E54-4AB9-A212-DA25B21F3391 Q37387521-2FFB40BE-0C5D-4597-93F7-3CD8E74975D0 Q37698523-6BED903D-D939-4BAF-939F-C7E41BEDC721 Q37703685-E27E248A-3D90-4B9B-9545-6C5E232E6DC1 Q38036949-C5EA70A2-43F8-4D49-9037-8462471627CB Q38069543-91499390-611B-4ABC-9D42-6FCE5271FF5D Q38078839-F49C078A-8200-4364-A72F-37989B929FC6

P2860

Bone, sweet bone--osteoporotic fractures in diabetes mellitus.

http://www.wikidata.org/entity/Q37976305

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Bone, sweet bone--osteoporotic fractures in diabetes mellitus.

@en

Bone, sweet bone--osteoporotic fractures in diabetes mellitus.

@nl

type

label

Bone, sweet bone--osteoporotic fractures in diabetes mellitus.

@en

Bone, sweet bone--osteoporotic fractures in diabetes mellitus.

@nl

prefLabel

Bone, sweet bone--osteoporotic fractures in diabetes mellitus.

@en

Bone, sweet bone--osteoporotic fractures in diabetes mellitus.

@nl

P1433

Q37976305-BBA8BA78-FB7E-47B0-A46C-C56B2FF4CA4C

P1476

Q37976305-BF967B14-073B-4E36-BEA6-DF774F671362

P2093

Q37976305-043492E3-6087-4981-BB31-69F172C699BD

Q37976305-2FFAE507-8108-45EB-928B-8DFCE80E98D7

Q37976305-4797D2FA-1C19-4BB3-B992-89153E31A861

P2860

Q37976305-0083A0CD-42AC-4C27-BB60-6D033FFCB010

Q37976305-08EC60DE-6913-40B2-9C5F-713A897D2B64

Q37976305-0CDE39F1-23F1-4E33-A016-B295492B6A59

Q37976305-11088703-4583-47AF-80F1-6C363FD82984

Q37976305-1B88EE82-11DE-4408-B77B-CCBA764D075A

Q37976305-1E8F6149-CE06-4A6F-99C8-01FA87EFACD8

Q37976305-1EAD58F5-417A-492F-9A68-1067B3E8190C

Q37976305-1FB6F48A-7C47-40C2-8FEA-169DF36DE26E

Q37976305-213BAA07-4898-4B4C-9DFE-4D86C36F61BE

Q37976305-21B9419F-D3CE-4A17-9AF0-83F41506241B

P2888

Q37976305-3C94F8CE-4C14-4F52-B444-A5E650B6B5C5

P304

Q37976305-1BD948CE-E0D0-4A0B-95AD-DD994FA2BE08

P31

Q37976305-C66F10D9-082D-499A-A633-7F7E56CFCC5D

P356

Q37976305-A5F5A74B-BCA2-4065-9969-8E22535AC981

P433

Q37976305-B84A5736-23E6-4592-99CF-AE32AF363723

P478

Q37976305-FBF94F66-13E8-4518-A6F2-DC1F45B1167A

P50

Q37976305-096115C2-B7EE-4D81-A3F3-A4F0345CF4B2

P577

Q37976305-7049B4CB-DEEC-4597-9D6B-DB57EE87651C

P5875

Q37976305-65211CA0-3C31-483B-B39F-6D42B9001184

P698

Q37976305-3FB9A6BA-5E47-4921-B901-55683036BADF

P921

Q37976305-6B9B018A-5466-425C-832E-8435ABCFA386

P356

NRENDO.2011.233

P1433

Nature Reviews Endocrinology

P1476

Bone, sweet bone--osteoporotic fractures in diabetes mellitus

@en

P2093

Christine Hamann

http://www.w3.org/2001/XMLSchema#string

Klaus-Peter Günther

http://www.w3.org/2001/XMLSchema#string

Stephan Kirschner

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

Endocrine regulation of energy metabolism by the skeleton

Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis

Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo

Vitamin D deficiency

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Matrix-embedded cells control osteoclast formation

Evidence for osteocyte regulation of bone homeostasis through RANKL expression

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Shared pathways of osteoblast mitogenesis induced by amylin, adrenomedullin, and IGF-1

P2888

nrendo.2011.233

P304

297-305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRENDO.2011.233

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Lorenz C Hofbauer

P577

2012-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221751650

http://www.w3.org/2001/XMLSchema#string

P698

22249517

http://www.w3.org/2001/XMLSchema#string

P921